Skip to main content
Caplight Logo









IRUBIS

IRUBIS

Private
MunichHealthcare & Life Scienceshttps://irubis.com/

Last Round

Pre Seed

Aug 29, 2024

Total Funding Raised

$4.73M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

IRUBIS is a biotechnology company that has developed a mid-infrared spectroscopy platform designed to monitor bioprocess parameters in real-time.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

bioprocess monitoringprocess analytical technologyPATinfrared spectroscopycell culture analysisbiotech lab automationat-line monitoringupstream bioprocessingbiopharma manufacturingCDMOreal-time process controlbiotech sensorssmart manufacturinglab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IRUBIS Comparables

Compare IRUBIS with similar companies based on industry and business-model similarity.

IRUBIS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nirrin Technologies
88%
CLADE
82%
GenSensor
80%

IRUBIS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 29, 2024
SeedOct 6, 2022
Convertible DebtMar 24, 2022
GrantMay 1, 2020

IRUBIS Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 123% MoM to 1.3K.

  • Jun 22, 2025

    Added S Pact, a biotechnology startup, as a customer.

IRUBIS Filings

Explore SEC and related filing metadata, where available.

IRUBIS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about IRUBIS's valuation, stock price, and market status.

Is IRUBIS a public or private company?

IRUBIS is a private company.

What is the current stock price of IRUBIS?

IRUBIS is a private company with no public stock price. No recent secondary market data is available.

How much is IRUBIS worth (valuation)?

Valuation information for IRUBIS is not publicly available.

Can I buy IRUBIS stock?

IRUBIS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was IRUBIS's last funding round?

IRUBIS's most recent funding round was Seed on August 29, 2024.

Who are the main investors in IRUBIS?

Key investors in IRUBIS include Verve Ventures, Ventura BioMed Investors.

Will IRUBIS IPO soon?

No public IPO plans have been announced for IRUBIS.

How can I track IRUBIS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IRUBIS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Employee Range17
Year Founded2017
Last FundingAug 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?